OncoSec Medical Inc (ONCSQ)

[mybikeisorange]

Nice post Tom. I haven't listened to the webinar, but sounds about like how I expected it would go.

Good to hear from someone that else understands the true extent of the Merck relationship. Thanks for confirmation on the P2b patient sample size. Again I haven't listened to the call, but my understanding was that the interim data possibly to presented in 4Q was for the P2a expanded study, not the P2b combo study. Can you confirm that?

I agree that everything depends on those P2b results. ONCS is putting the pieces together now in preparation for those results to be positive. If positive, good things will happen. We still have a long way to go though.